Latest Metformin Stories
The drug saxagliptin (trade name: Onglyza) has been approved also as monotherapy in Germany since July 2013 for certain adults with type 2 diabetes mellitus.
A single overactive enzyme worsens the two core defects of diabetes—impaired insulin sensitivity and overproduction of glucose—suggesting that a drug targeting the enzyme could help correct both at once.
A new study published online in The Oncologist journal shows that cancer patients with concurrent type 2 diabetes treated with metformin have a greater overall survival rate compared with patients
Metformin may reduce food intake and body weight, but the anorexigenic effects of metformin are still poorly understood.
Researchers from McMaster University in Hamilton, Ontario have discovered how metformin, one of the world’s most commonly prescribed diabetes drugs, interacts with insulin in order to lower a person’s blood sugar.
- A political dynamiter.